Inventor
KOSEMUND DIRK
DE43 patents
⚠️ This page may combine multiple inventors who share the name “KOSEMUND DIRK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
14 patentsUS9540392B2Jan 10, 2017
Thienopyrimidines
Bayer Pharma AG2 citations72
US9670202B2Jun 6, 2017
Substituted triazolopyridines
Bayer Pharma AG2 citations62
US9499492B2Nov 22, 2016
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
Bayer Pharma AG1 citations52
US9877954B2Jan 30, 2018
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma AG1 citations51
US9670161B2Jun 6, 2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations51
US9650340B2May 16, 2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma AG1 citations51
US9770445B2Sep 26, 2017
Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors
Bayer Pharma AG0 citations48
US9856242B2Jan 2, 2018
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations42
US9902716B2Feb 27, 2018
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
Bayer Pharma AG0 citations41
US9884849B2Feb 6, 2018
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
Bayer Pharma AG0 citations41
US9708293B2Jul 18, 2017
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations41
US9296757B2Mar 29, 2016
Substituted benzothienopyrimidines
Bayer Pharma AG0 citations41
US10428083B2Oct 1, 2019
Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor
Bayer Pharma AG0 citations39
US9586958B2Mar 7, 2017
Prodrug derivatives of substituted triazolopyridines
Bayer Pharma AG0 citations38
SCHERING AG
6 patentsUS7414043B2Aug 19, 2008
9-α-substituted estratrienes as selectively active estrogens
SCHERING AG56 citations93
US6583130B1Jun 24, 2003
C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
SCHERING AG18 citations82
US7504410B2Mar 17, 2009
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
SCHERING AG13 citations81
US6670347B2Dec 30, 2003
19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring
SCHERING AG2 citations62
US7109360B1Sep 19, 2006
16-hydroxyestratrienes as selectively active estrogens
SCHERING AG6 citations61
US6794409B2Sep 21, 2004
Use of ERβ-selective ligands for regulating fertility and compounds useful therefor
SCHERING AG1 citations51
KLAR ULRICH
4 patentsLücking Ulrich
4 patentsUS9133171B2Sep 15, 2015
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
Lücking Ulrich5 citations72
US9669034B2Jun 6, 2017
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Lücking Ulrich2 citations71
US8916557B2Dec 23, 2014
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines
Lücking Ulrich4 citations71
US9108926B2Aug 18, 2015
Disubstituted 5-fluoro-pyrimidines
Lücking Ulrich1 citations51